Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

The evolution of COVID-19 epidemiology in Italy over the first two years of the pandemic

A recent study assessed the SARS-CoV-2 lethality and severity during the two years of the SARS-CoV-2 pandemic in Italy.

5 Jul 2022

The varying patterns of acute respiratory infection hospitalizations before and during two pandemic years

Investigators analyzed the varying pattern of respiratory viruses resulting in hospitalizations from 2012-2013 to 2021-2022 in Canada.

5 Jul 2022

Study looks at pneumococcal carriage among over 60's during COVID pandemic

In a recent article posted to the medRxiv* preprint server, researchers in the United States analyzed the pneumococcal carriage in older adults in the Greater New Haven Area, United States (US), during the implementation of coronavirus disease 2019 (COVID-19) mitigation strategies.

4 Jul 2022

Impact of SARS-CoV-2 infection on menstrual cycle

Researchers systematically reviewed the impact of COVID-19 on the menstrual cycle.

4 Jul 2022

COVID pandemic may have hidden a significant increase in child abuse, say doctors

UK doctors are concerned that the COVID pandemic may have hidden a significant increase in child maltreatment. Speaking at the United Kingdom Imaging and Oncology Congress in Liverpool, Professor Owen Arthurs (Great Ormond Street Hospital, London) called for greater resources to detect abuse, especially if future COVID waves lead to new lockdown conditions.

4 Jul 2022

Discussing tools and resources to support the bladder cancer patient community

In this interview, Dr. Ignacio Durán and Alex Filicevas discuss key challenges and opportunities in the bladder cancer disease landscape and the future of care. This episode focuses on the bladder cancer patient support landscape, including a review of the tools and resources available to the community, as well as key unmet needs to address.

From Janssen Pharmaceuticals 4 Jul 2022

The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection

A new study focused on determining Vitamin D's role in SARS-CoV-2 and H1N1 influenza. In this study, researchers determined the effect of vitamin D supplements on the lung anti-viral response in animal models.

4 Jul 2022

Age-specific precision shielding in the pre-vaccination period of the COVID-19 pandemic

A new study has focussed on addressing whether age-specific precision shielding was achieved in the pre-vaccination period.

4 Jul 2022

Repeat nursing homes transfers are much higher for Black residents and those under age 65, study finds

Nursing homes transfer roughly 25% of their residents to the hospital at least once, at a cost of $14.3 billion to Medicare, according to a federal report by the Office of Inspector General.

1 Jul 2022

New insights about societal resilience during the COVID-19 pandemic

A video-interview with a resident epidemiologist from the CORONADX project discusses about societal resilience during the COVID-19 pandemic.

1 Jul 2022

Brigham receives $16 million Helmsley Charitable Trust grant to improve healthcare delivery for NCDs

Brigham and Women's Hospital announces a $16 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to support the implementation and evaluation of an integrated service delivery model (PEN-Plus) for severe chronic noncommunicable diseases (NCDs) such as type 1 diabetes, rheumatic heart disease, cardiomyopathies, and sickle cell disease in eight low- and lower-middle-income countries in sub-Saharan Africa and South Asia.

1 Jul 2022

Study highlights the pressing need to support people who have been shielding from Covid-19

Research from a new study suggests that health anxiety among the clinically vulnerable groups who shielded at home has risen since the first pandemic wave, despite developments in viral treatment and the roll-out of the vaccination programme.

1 Jul 2022

Most therapeutic antibodies for treating COVID-19 patients do not inhibit emerging Omicron subvariants

The Omicron subvariants BA.1 and BA.2 of SARS-CoV-2 have dominated the COVID-19 pandemic in early 2022. In many countries, these viruses are now outcompeted by emerging subvariants, with BA.5 being responsible for the current uptick of cases in Germany.

1 Jul 2022

New antibody-based method for SARS-CoV-2 detection does not require a blood sample

Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over. A key challenge in limiting the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is identifying infected individuals.

1 Jul 2022

Scientists develop antibody test to keep track of immunity to SARS-CoV-2 variants

The experts agree - the pandemic is not over. Infections are ticking up again, fueled by the new variants our immune systems are ill prepared for.

1 Jul 2022

Remdesivir resistance in renal transplant patients with long COVID-19

A new study has reported two renal transplant cases, in which individuals, after being exposed to remdesivir, developed a resistance to the drug.

1 Jul 2022

How to get rid of medical debt — or avoid it in the first place

Lori Mangum was 32 when apple-size tumors sprouted on her head. Now — six years and 10 surgeries later — the skin cancer is gone. But her pain lives on, in the form of medical debt.

1 Jul 2022

Combining AI and Zebrafish to Accelerate Drug Discovery

As part of our SLAS Europe 2022 coverage, we speak to Dr. Javier Terriente, Co-founder and Chief of Drug Development at ZeClinics, about how zebrafish could be the future for discovering new therapeutics.

From Society for Laboratory Automation and Screening (SLAS) 1 Jul 2022

SARS-CoV-2 can evade Paxlovid by multiple mechanisms

In a recent article posted to the bioRxiv* preprint server, researchers at Rutgers, the State University of New Jersey, the University of South Florida, and the Catholic University of America demonstrated that the natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) mutations result in nirmatrelvir resistance.

30 Jun 2022

Mosaic-8 RBD-nanoparticles show promise against current and future SARS-CoV-2 variants

A recent study posted to the bioRxiv* preprint server supports using mosaic sarbecovirus receptor-binding domain (RBD)-nanoparticles to discover therapeutic pan-variant and pan-sarbecovirus monoclonal antibodies (mAbs) and to induce mAbs by vaccination.

30 Jun 2022

Pandemic News and Research

Further Reading

The evolution of COVID-19 epidemiology in Italy over the first two years of the pandemic

The varying patterns of acute respiratory infection hospitalizations before and during two pandemic years

Study looks at pneumococcal carriage among over 60's during COVID pandemic

Impact of SARS-CoV-2 infection on menstrual cycle

COVID pandemic may have hidden a significant increase in child abuse, say doctors

Discussing tools and resources to support the bladder cancer patient community

The role of vitamin D in H1N1 influenza and SARS-CoV-2 infection

Age-specific precision shielding in the pre-vaccination period of the COVID-19 pandemic

Repeat nursing homes transfers are much higher for Black residents and those under age 65, study finds

New insights about societal resilience during the COVID-19 pandemic

Brigham receives $16 million Helmsley Charitable Trust grant to improve healthcare delivery for NCDs

Study highlights the pressing need to support people who have been shielding from Covid-19

Most therapeutic antibodies for treating COVID-19 patients do not inhibit emerging Omicron subvariants

New antibody-based method for SARS-CoV-2 detection does not require a blood sample

Scientists develop antibody test to keep track of immunity to SARS-CoV-2 variants

Remdesivir resistance in renal transplant patients with long COVID-19

How to get rid of medical debt — or avoid it in the first place

Combining AI and Zebrafish to Accelerate Drug Discovery

SARS-CoV-2 can evade Paxlovid by multiple mechanisms

Mosaic-8 RBD-nanoparticles show promise against current and future SARS-CoV-2 variants

Best practices - optimize qPCR processes for pathogen detection eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News